• Tuesday 03 July 2018
  • 09:00
    Plenary session: WHO is afraid of fungus

    Carmen da Silva, Switzerland
  • 10:00
    Break
  • 10:30
    Parallel session VII

    Parallel session VII will take place from 10:30 hrs. until 12:00 hrs. and consists of seven symposia.
  • S7.1 Fungal biofilms

    Convener: Gordon Ramage, United Kingdom
    • 10:30
      S7.1a Candida auris and non-albicans biofilms

      Gordon Ramage, United Kingdom
    • 10:55
      S7.1b insights into new antibiofilm molecules

      Jose Lopez-Ribot, USA
    • 11:20
      S7.1c Induction of trained innate immunity against fungal/bacterial sepsis

      Bastian Krom, the Netherlands
    • 11:45
      S7.1d selected abstracts
  • S7.2 Fungal Interactions with Epithelium Trigger Innate Immune Activation

    Convener: Andrew Limper, USA
    • 10:30
      S7.2a Epithelial Activation by Candida species

      Julian Naglik, United Kingdom
    • 10:55
      S7.2b The Immunopathogenesis of Candida Vaginitis

      Bruce Klein, USA
    • 11:20
      S7.2c Pneumocystis Activation of Innate Immune Responses by Lung Epithelial Cells

      Andrew Limper, USA
    • 11:45
      S7.2d selected abstracts
  • S7.3 The Real Pathogens: Ajellomycetaceae

    Convener: Anastasia Litvintseva, USA
    • 10:30
      S7.3a Emerging Emergomyces africanus in Africa

      Nelesh Govender, South Africa
    • 10:55
      S7.3b Migration of Coccidioides posadasii into South America

      Bridget Barker, USA
    • 11:20
      S7.3c Ecology and geographic distribution of Coccidioides

      Anastasia Litvintseva, USA
    • 11:45
      S7.3d selected abstracts
  • S7.4 Why do patients get aspergillosis?

    Convener: Adilia Warris, United Kingdom
    • 10:30
      S7.4a Influenza-associated aspergillosis

      Frank van Veerdonk, the Netherlands
    • 10:55
      S7.4b Aspergillus-derived secreted products driving invasion of pulmonary epithelia

      Elaine Bignell, United Kingdom
    • 11:20
      S7.4c Defective antifungal immunity in cystic fibrosis

      Adilia Warris, United Kingdom
    • 11:45
      S7.4d selected abstracts

  • S7.5 Scedosporium

    Conveners: Sharon Chen, Australia & Michaela Lackner, Austria
    • 10:30
      S7.5a Virulence mechanisms in Scedosporium with a particular focus on respiratory infections in cystic fibrosis

      Jean-Philippe Bouchara, France
    • 10:55
      S7.5b NCT a potential agent for the topical treatment of scedosporiosis and lomentosporiosis

      Michaela Lackner, Austria
    • 11:20
      S7.5c Diversity within the genera Lomentospora and Scedosporium

      José Cano, Spain
    • 11:45
      S7.5d Infections with Scedosporium/Lomentospora from an Australian perspective  - are we at the end  of the road

      Sharon Chen, Australia
  • S7.6 Sporothrix WG

    Convener: Leila Lopes-Bezerra, Brazil
    • 10:30
      S7.6a RNA-seq and transcriptome-wide analysis of Sporothrix schenckii yeast and mycelial forms

      Orazio Romeo, Italy
    • 10:55
      S7.6b Sprothrix globosa causing sporotrichosis in Jilin Province (Northeast of China):Prevalence,Molecular Characterization,and Antifungal Susceptibility

      Shanshan Li, China
    • 11:20
      S7.6c Human serum factors impact the interaction of Sporothrix spp. with human macrophages

      Leila Lopes Bezerra, Brazil
    • 11:45
      S7.6d selected abstracts
  • S7.7 Pediatrics

    Convener: Andreas Groll, Germany
    • 10:30
      S7.7a Concepts of pediatric drug development and new antifungal agents

      Andreas Groll, Germany
    • 10:55
      S7.7b Diagnostic biomarkers and imaging – what is different in Pediatrics

      Thomas Lehrnbecher, Germany
    • 11:20
      S7.7c Epidemiology and outcome of IFD in pediatric patients: The Southern hemisphere

      Fabianne Carlesse, Brazil
    • 11:45
      S7.7d Epidemiology and outcome of IFDs in pediatric patients: The Northern Hemisphere

      Emmanuel Roilidis, Greece
  • 12:00
    Lunch break, exhibition, posters
  • 12:30
    Sponsored symposium IV
  • 13:30
    Plenary session: Interaction of Aspergillus fumigatus with neutrophilic granulocytes

    Axel Brakhage, Germany
  • 14:30
    Break
  • 15:00
    Parallel session VIII

    Parallel session VIII will take place from 15:00 hrs. until 16:30 hrs. and consists of six symposia.
  • S8.1 Host-pathogen interactions - the pathogen perspective

    Convener: Bernhard Hube, Germany
    • 15:00
      S8.1a Interactions of Candida albicans with the host

      Bernhard Hube, Germany
    • 15:25
      S8.1b The immunoglycobiology of fungal pathogens

      Hector Mora-Montes, Mexico
    • 15:50
      S8.1c Aspergillus fumigatus

      Jean-Paul Latge, Franc
    • 16:15
      S8.1d selected abstracts
  • S8.2 Milestones in medical mycology: history in modern light

    Convener: Luciano Polonelli, Italy
    • 15:00
      S8.2a Taxonomic benchmarks in mycotoxinogenic fungi

      Robert Samson, the Netherlands
    • 15:25
      S8.2b Nystatin and the women who founded the antifungal era

      Chet Cooper, USA
    • 15:50
      S8.2c History of Cryptococcus and cryptococcosis

      Wanqing Liao, China
    • 16:15
      S8.2d selected abstracts
  • S8.3 Management of fungal resistance

    Convener: Oliver Lortholary, France
    • 15:00
      S8.3a T.b.a.

      Oliver Lortholary, France
    • 15:25
      S8.3b T.b.a

      Arnaldo Colombo, Brazil
    • 15:50
      S8.3c Infections with Scedosporium/Lomentospora from an Australian perspective  - are we at the end  of the road 

      Sharon Chen, Australia
    • 16:15
      S8.3d selected abstracts
  • S8.4 The Mycobiome in Health and Disease

    Convener: Mahmoud Ghannoum, USA
    • 15:00
      S8.4a Mycobiome and Bacteriome Interactions: Vital Key of Health and Disease

      Mahmoud Ghannoum, USA
    • 15:25
      S8.4b Obesity: Link between Mycobiome and their Metabolites

      T.b.a.
    • 15:50
      S8.4c The Mycobiota: Interactions between Commensal Fungi and the Host

      David Underhill, USA
    • 16:15
      S8.4d selected abstracts
  • S8.5 Challenges in mucosal and invasive candidiasis

    Conveners: Stavroula Antonoupolus, Greece & Jesus Ortega, Spain
    • 15:00
      S8.5a T.b.a

      Flavia De Bernardis, Italy
    • 15:25
      S8.5b T.b.a.

      Patricia Munoz, Spain
    • 15:50
      S8.5c - Hidden echinicandin resistance induction due to abdominal candida infection

      Neil Clancy, USA
    • 16:15
      S8.5d selected abstracts
  • S8.6 ECMM/ISHAM rare fungal infections

    Conveners: Oliver Cornely, Germany & Raoul Hebrechts, France
    • 15:00
      S8.6a Challenges in treatment of IFD in children

      Thomas Lernbecher, Germany
    • 15:25
      S8.6b Genetic predictors of response to antifungals in IFD

      Michaela Lackner, Austria
    • 15:50
      S8.6c Responsibilities of a trans-regional laboratory in mycological diagnostics

      T.b.a.
    • 16:15
      S8.6d selected abstracts
  • 16:30
    Parallel session IX

    Parallel session IX will take place from 16:30 hrs. until 18:00 hrs. and consists of six symposia.
  • S9.1 Genotyping in the NGS era

    Convener: Stephane Bretagne, France
    • 16:30
      S9.1a Tracing the evolution of virulence in Cryptococcus neoformans using population sequencing

      Christina Cuomo, USA
    • 16:55
      S9.1b NGS and Aspergillus fumigatus : from the environment to the clinics

      T.b.a.
    • 17:20
      S9.1c NGS and typing of Candida albicans: just an improvement of other typing methods?

      Christophe d Enfert, France
    • 17:45
      S9.1d selected abstracts
  • S9.2 Developments in Chinese medical mycology

    Convener: Ruoyu Li, China
    • 16:30
      S9.2a Anti-IFN-autoantibodies in adults with disseminated Talaromyces marneffei infections are associated with HLA-DRB1*16:02 and the Cellular Immune Responses in the patients

      Cunwei Cao, China
    • 16:55
      S9.2b CARD9 deficiency and dematiaceous fungal infections

      Xiaowen Wang, China
    • 17:20
      S9.2c Exploring the pathogenic roles of  Fonsecaea cell wall melanin through case to bench study

      Jiufeng Sun, China
    • 17:45
      S9.2d selected abstracts
  • S9.3 Dosing antifungal from the XXS to XXXL

    Convener: Roger Brüggeman, the Neterlands
    • 16:30
      S9.3a T.b.a
    • 16:55
      S9.3b from mother to child and their ontogeny with a focus on antifungal drugs

      Catherine Sherwin, USA
    • 17:20
      S9.3c what if every organ fails – the critically ill patients that need antifungal treatment

      T.b.a.
    • 17:45
      S9.3d the heavy weight championship – impact of obesity on pharmacokinetics and dynamics

      Catherijne Knibbe, the Netherlands
  • S9.4 MALDI-TOF in filamentous fungi

    Convener: Maurizio Sanguinetti, Italy
    • 16:30
      S9.4a T.b.a.

      Maurizio Sanguinetti, Italy
    • 16:55
      S9.4b Filamentous fungi MALDI-TOF identification in the clinical laboratory

      Stéphane Ranque, France
    • 17:20
      S9.4c T.b.a.

      Marijke Hendrickx, Belgium
    • 17:45
      S9.4d selected abstracts
  • S9.5 Recent advances in diagnosing aspergillosis

    Convener: Shigeru Kohno, Japan
    • 16:30
      S9.5a How to standardize Aspergillus PCR protocols for testing various specimens

      Lewis White, United Kingdom
    • 16:55
      S9.5b Potential for detection of Aspergillus by Electronic Nose Technology

      T.b.a.
    • 17:20
      S9.5c Detection of Invasive Pulmonary Aspergillosis in Mice Using Lung Perfusion Single-Photon Emission Computed Tomography with 99mTc-MAA

      Masato Tashiro, Japan
    • 17:45
      S9.5d selected abstracts
  • S9.6 FungiScope WG

    Convener: Danilia Seidel, Germany
    • 16:30
      S9.6a Going steady: FungiScope, a worldwide effort in researching rare fungal diseases

      Danilia Seidel, Germany
    • 16:45
      S9.6d Rare invasive yeast infections

      Luisa Durán Graeff, Chile
    • 16:55
      S9.6b Taxonomy of Mucor

      Lysett Wagner, Germany
    • 17:20
      S9.6c Challenges in clinical management of mucormycosis in children

      Zoe Pana, Greece
  • 18:00
    Closing
  • 19:00
    Congress dinner